Sun Pharmaceutical Industries completes acquisition of Concert Pharmaceuticals

08 Mar 2023 Evaluate

Sun Pharmaceutical Industries has successfully completed acquisition of Concert Pharmaceuticals, Inc., a late-stage clinical biopharmaceutical company that is developing deuruxolitinib, a novel, deuterated, oral JAK1/2 inhibitor, for the potential treatment of adult patients with moderate to severe alopecia areata. By bringing together Concert’s talented team with Sun Pharma’s global reach and commercial capabilities, this acquisition is an opportunity to bring deuruxolitinib to market globally and make a meaningful difference to alopecia areata patients around the world.

Sun Pharmaceutical Industries is the world's fourth largest specialty generic pharmaceutical company and India's top pharmaceutical company.

Sun Pharma Inds. Share Price

1785.00 -41.10 (-2.25%)
10-Jan-2025 16:01 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1785.00
Dr. Reddys Lab 1354.20
Cipla 1475.25
Lupin 2185.50
Zydus Lifesciences 1003.00
View more..
© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.